Immix Biopharma, Inc.
Immix Biopharma, Inc. scores highest on Torque (69) and lowest on Price (22). Its PosiPenta is 51.43 out of 100, around the middle of similar companies.
On the Penta Grid this week, Immix Biopharma, Inc. is Grid #263 of 837 in the Healthcare sector in United States, and Grid #1,718 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Immix Biopharma, Inc. | 51.43 | 22 | 39 | 59 | 69 | 68 |
| OmniAb, Inc. | 55.46 | 24 | 50 | 88 | 61 | 54 |
| Iambic Therapeutics, Inc. | 44.33 | 0 | 26 | 94 | 64 | 38 |
| Nuvectis Pharma, Inc. | 42.37 | 1 | 42 | 69 | 51 | 49 |
| The Oncology Institute, Inc. | 65.20 | 0 | 68 | 92 | 99 | 68 |
| Sagimet Biosciences Inc. | 47.34 | 26 | 33 | 72 | 70 | 35 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -9.07 |
| P/B ratio | 2.89 |
EEarnings
| Trailing EPS | ₹-83.35 |
| Forward EPS | ₹-80.27 |
NNitro
| Price | 755.83 |
| 52-week high | 1430.20 |
| 52-week low | 252.89 |
| Fall from 52-week high | 47.2% |
TTorque
| Return on equity (ROE) | -34.18% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 0.24 |
| Market cap | ₹6,266 Cr |
| Insider holding | 14.78% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Immix Biopharma, Inc.'s PosiPenta score?
Immix Biopharma, Inc.'s PosiPenta is 51.43 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Immix Biopharma, Inc. stand on the Penta Grid?
On the Penta Grid this week, Immix Biopharma, Inc. is Grid #263 of 837 in the Healthcare sector in United States, and Grid #1,718 of 4,000 in United States.
Which PosiPenta pillar is strongest for Immix Biopharma, Inc.?
Torque (durability), with a score of 69 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Immix Biopharma, Inc.?
Price (valuation), with a score of 22 out of 100: weaker than most similar companies.
Has Immix Biopharma, Inc.'s PosiPenta changed since last week?
Yes, it rose 2.36 points, from 49.07 to 51.43.
PositoAI is for research and education only and is not investment advice.